Photo of Jennifer Buell from LinkedIn
Oct 3, 2023, 16:52
Jennifer Buell: MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023 – Bloomberg.
Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared a post by Bloomberg on X/Twitter:
“MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023 – Bloomberg”.
Source: Jennifer Buell/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 18, 2024, 02:49
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:14